📰 Grant Date News
Page 34 - Grant Date News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Grant Date. Real-time updates on events, politics, business and more.
November 4, 2021
/PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on developing and commercializing multimodal...
October 30, 2021
30.10.2021 - CAMBRIDGE, Mass., Oct. 29, 2021 (GLOBE NEWSWIRE) - Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on October 29, 2021 that were previously approved by the Compensation ...
October 14, 2021
/PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors...
October 14, 2021
/PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors...
July 9, 2021
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) News provided by Share this article Share this article SEATTLE, July 8, 2021 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an authorized subcommittee of the Compensation Committee of its Board of Directors granted an equity award to a new employee as an equity inducement award outside of the Companys Amended and Restated 2017 Equity Incentive Plan (but under the terms of the Amended and Rest...
July 5, 2021
Dev Clever (LSE: DEV) is pleased to announce its unaudited interim results for the six months ended 30 April 2021 (the Period"). Financial Highlights: · Revenue up 531% at £2.4m for the Period (H1 2020: £383k) and supported by significant contract wins in the Educate division. · EBITDA loss of £162k (H1 2020: loss of £561k), which includes non-cash share-based expenses of £201k (H1 2020: £44k). · Adjusted ...
June 11, 2021
Investegate announcements from Premier Foods plc, Director/PDMR Shareholding
May 26, 2021
/PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that the Compensation Committee of its Board of Directors granted equity awards to six new...